CMS Proposes Overhaul of Medicare Advantage Star Ratings, Shifts Focus to Outcomes

The Centers for Medicare and Medicaid Services (CMS) has proposed significant revisions to the Medicare Advantage (MA) Star Ratings system, which evaluates the quality of MA plans through multiple measures. The proposal involves removing 12 administrative-focused measures, such as timely appeals decisions, availability of foreign language interpreters, and customer service metrics, emphasizing a shift towards patient outcomes. These changes respond to legal challenges from insurers like SCAN Health Plan, Humana, and Elevance, which had contested certain components of the Star Ratings. The Star Ratings not only guide beneficiaries in plan selection but also impact financial bonus payments that insurers use to enhance member benefits. CMS also plans to introduce a new depression screening and follow-up measure in the 2029 ratings cycle, while discontinuing the Excellent Health Outcomes for All reward, a former incentive tied to reducing health disparities among socially at-risk populations. Healthcare experts express mixed views: some recognize the intent to focus on clinical outcomes and patient experience by removing less meaningful metrics, whereas others caution that eliminating administrative measures might reduce accountability on aspects critical to member navigation and appeal processes. Concerns also arise regarding the removal of the health equity reward, given its role in addressing health disparities in Medicare populations. Stakeholders including the Better Medicare Alliance emphasize the need for a stable, transparent, and fair rating system that supports predictability for beneficiaries and providers, particularly for plans serving high-risk groups. The CMS Administrator highlighted the commitment to rewarding innovations in quality and simplifying beneficiary comparisons. Overall, the proposal indicates a regulatory shift prioritizing outcome-based measures yet raises questions about the balance between administrative oversight and quality improvements in Medicare Advantage plan evaluations.